Member Info for itsallamess

Somehow I missed this. Updated on jan 4th
https://www.faron.com/sites/default/files/Faron%20corporate%20deck%20Jan%202022_1.pdf

Should have a deeper look at sesei, see what value she added... If she was a great value to them could we see some of the smarter investors over there follow her to here?

Wondering the reason for Marie-Louise Fjällskog to be joining us.

Her Linkin profile shows she spends around one and a half years in a company then moves on.

Sensei seems like it's a few years from going to market with their drugs. So I'm thinking she has joined us because we are nearer the endgame?
In any case she is a ladder climber so draw comfort from the fact we are classed as a bigger fish.

Boston connection is interesting as is her being part of Sensei listing on the US markets via an IPO.

sounds more like our next round of funds will be via a US listing.

The thing with US listing is that their prices can become quite volitile. Sensei was up 19 dollars today around 6 dollars.

What would a US listing mean for us? The share price could shoot up quite Alot but maybe I would have to give some serious thought about holding or selling! Don't get to attached to a share, as they say!

Give me 25 and I would happily sell.

She Wil focus on bex.. That the future at the moment of Faron so we can expect some great data to be released. I can't imagine a new CMO would join us if she didn't know we have a major breakout to be recognised.

Think about this. Merck buys us out to get its hands on bex.

Let's face it a big pharma who already has their foot in the door with keytruda and then have bex as a combination therapy is a winning formula for them.

Pretty sure I remember markku saying he would be open to a buy out!

We just need patience here and not to get to concerned with the share price (easier said than done) but what's the difference between a fragile rise to double figures or a massive jump on sell out news! (If that was the case)

Pretty disappointed at this drift in the share price. I know this time of year nothing is happening, but still for months now we have been slowly bleeding out.

Come on markku do something other than PR just before a cash raise.

https://www.linkedin.com/feed/update/urn:li:activity:6874618209543172096?commentUrn=urn%3Ali%3Acomment%3A%28activity%3A6874618209543172096%2C6875112405077123072%29

Totally agree sax.

I think back to the last interview, marrku was saying something to the effect the discovery they made should be availible to the world.

Yes we have 3 types of cancer here, but as we are learning bex works on some of those paitents in those cancer types and others not. Identifying why will move bex to becoming a treatment.

What about all other cancer types? It could well be possible that Bex works for some of those paitents and if the simple blood test will show this then the door is open to them as well.

What's interesting is not one type of immunotherapy works for everyone. Maybe in a few years we will have a patient tested and the doctor simply looks down a list and assigns the correct immunathey treatment for that individual.

Keytuda is one type
Bex another
Plus others

All in all its progress and faron is a large part to this.

What is good is that they have identified a reason why the paitents responded to bex and others not.

what it means is they could pre test cancer paitents with a simple test and if they have these biomarkers then they know beforehand who bex is good for.

In effect they could do a trial and have 100% success rate.

This is the news we wanted after the last bex trial and what's great, they were able to get this info from the data collected before.

Why is the share price not reflecting this? Anyones guess!

https://twitter.com/tonih77/status/1467576464489041925?t=2LUlaWY5ByPxX3Jet_M6_g&s=19

Makes me wonder if any of this news was mentioned to the EIC when Toni H our CFO met with there rep last week!

Im sure the EIC would invest more in companies that they se results from privios investments.

They want to see European companies succeed, if they are making leaps in advances surely they would be easily convinced to hand over more cash.

Well I've not sold and will not be selling at all as this picture plays out.

Very excited about bex potential here.

Very good news.

We are getting closer guys.

So what do we know? Bex works but it's identifying who on which it looks like they are nearly there!

And being able to identify who with a simple test rather than costly biopsies..

2 words stood out 'bexmarilimab monotherapy'

So they tested on 3 types of cancers. I'm sure they will be looking into all the other cohorts to see if the same test would identify who would benifit from bex as well!

This is why the large investors like Tom Lind and Timo and the eoro fund keep investing more money.

It never droped to 2.80 in november. But I get your point. We worry when the price drops but those with cash rub their hands together with glee.

I think it was an old interview with Warren buffet who said he loves it when a company stock falls. That's the time he buys!
As the say, know what you own

Make that shares 44,095,701

Which man's the top 30 Shareholders own 82.84% percent of the shares and last month some sold (ie citi Bank) but over all they increased there shares.

Only 17.16% of the shares are owned by everyone else!

The free float is tiny, so when we do get price sensitive news we will move fast.

Hold in there guys. We are expanding, more data is coming in. I know things have gone a little silent but they are working in the back ground.

https://www.faron.com/investors/aim-rule-26
Within the top 30 Shareholders who now own 444,095,701 shares between them, some bought more, in fact another 2,159,900 shares (5.15% more shares) last month

All thanks goes to Saxondale. He has been quite proactive on twitter and our CFO replied to his tweet!

https://twitter.com/tonih77/status/1466418309197406216?t=CEgFALyXkqVsxSksJXUhCg&s=19

Has anyone seen this
https://www.google.com/url?sa=t&source=web&rct=j&url=https://www.mdpi.com/2072-6694/13/23/5988/pdf&ved=2ahUKEwi_8aOXl8f0AhVTfMAKHbLKC00QFnoECAUQAQ&usg=AOvVaw34Cyt47Hd_tsnRq92RFnPO

Very complicated stuff, but 'I think' it's the results of a study to try to figure out who bex works on?

I concur, not much to say while we await stuff whatever that is!

Is Something big is happening in the background.
Marrku Flys to the states and we don't really know why.
US listing talked about.
Office set up in the states.
CMO living with immediate effect.
Temp CMO in his place.

What if our new, yet to be announced CMO is part of a partnership agreement with a big pharma.

Answers on postcard please

Maybe that's why he left. We are now becoming more focused on oncology. When he joined the team it was ARDS focused.

We now need a CMO who is more aligned to the direction the company is heading.

Good news!

Cwebb, my thoughts exactly. Seems vaccines are more like a bandage over a burst pipe than a solution.

Perhaps the solution is treating a covid paitent, and Traumakine is the solution for intensive care paitents

Interesting video for anyone who is interested. The armidh community let covid sweep through them early on and now they live their normal lives.
https://youtu.be/O1DgWYdukZU

Realistically we have a couple of weeks to get some price moving info and then everything goes quite as we go into Christmas.

Come on Marku, do something that will make your share holders happy